About Contact Us Careers
Sign In

Human Combinatorial Antibody Libraries (HuCAL) Market - Top Companies and Manufacturers

  • Report ID: 5914
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Companies Dominating the Human Combinatorial Antibody Libraries (HuCAL) Market

    • MorphoSys A.G.
      • Company Overview
      • Business Planning
      • Main Product Offerings
      • Financial Execution
      • Main Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Bio-Rad
    • Adimab, LLC
    • Taurus Biosciences
    • ImmunoGen
    • BioInvent International AB
    • Creative Biolabs
    • YUMAB GmbH
    • Hoffman-La Roche Ltd.
    • Creative Biolabs
Browse Key Market Insights with Data Illustration:

In the News

February 5, 2024: MorphoSys AG, declared that it entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG dependent on Novartis' intention to deliver a voluntary public takeover deal for all of MorphoSys' superior common shares in exchange for money of € 68.00 per share.

January 30, 2024: MorphoSys AG reported preliminary Monjuvi® U.S. net material sales and gross margin for Monjuvi U.S. net product sales for the complete year of 2023 and given its 2024 financial assistance. In this environment, MorphoSys limits its financial liability from the cooperation with its partner Incyte and credits finance income consequently.


Author Credits:  Radhika Pawar


  • Report ID: 5914
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of human combinatorial antibody libraries is estimated at USD 169.85 million.

The human combinatorial antibody libraries market size was over USD 163.06 million in 2024 and is anticipated to cross USD 303.69 million by 2037, witnessing more than 4.9% CAGR during the forecast period i.e., between 2025-2037. Continuously increasing burden of hepatitis across the world will fuel the market growth.

North America industry is poised to hold largest revenue share of 35% by 2037, owing to increasing advancement in creating antibodies for reproducible research.

The major players in the market are Bio-Rad, MorphoSys A.G., Taurus Biosciences, ImmunoGen, BioInvent International AB, Creative Biolabs, YUMAB GmbH, Hoffman-La Roche Ltd., Creative Biolabs, Astellas Pharma Inc., Shinogi Inc., Koutai Shokunin, Daichi Sankyo Co., Ltd.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample